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Background: In mild to moderate gallstone pancreatitis, cholecystectomy is the most appropriate treatment for
prevention of further biliary attacks. However, the timing of cholecystectomy is not precisely determined. The
present study was conducted to compare outcomes of very early (within 48 h) versus delayed (more than 1 week)
laparoscopic cholecystectomy in patients with acute biliary pancreatitis (ABP).
Methods: This randomized clinical trial study was conducted in Shahid Beheshti Hospital of Kashan University of
Medical Sciences from September 2016 to Mar 2019. Two hundred and eight cases with mild to moderate ABP
were randomly assigned to 2 groups, with 104 patients in group 1 (operation within 48 h) and 104 in group 2
(operation after one week). Age, sex, biochemical parameters, clinical manifestation at the time of admission,
operation time, recurrent biliary problems, relapse, peri-operative complications, conversion rate, and hospital
length of stay in the two groups were recorded and compared. In addition, Ranson's score and Revised Atlanta
criteria, the American Society of Anaesthesiologists Physical Status ASA-PS, Charlson Co-Morbidity Index (CCI),
complexity of surgery and Clavien-Dindo score were also determined.
Results: There were no differences in demographics, peri-operative complications 4 (4%) vs. 4 (4%), P ¼ 1),
conversion rate (10.6% vs. 11.5%; P ¼ 0.825) and procedure time (83 vs. 81 minutes, P ¼ 0.110) between the two
groups. There were no deaths in either group; however, the length of hospital stay was shorter in the early group
compared to the delayed one, (3.66  1.12 vs. 10.35  1.76, P < 0.001).
Conclusion: Cholecystectomy within 48 h decreases significantly the length of hospital stay, without any difference
in conversion rate, procedure time, or complication rate.1. Introduction
Acute biliary pancreatitis (ABP) is a disease, most commonly due to
biliary calculi, followed by alcohol intake (19.7%) [1]. In 80% of cases it
has a mild to moderate course but in the remaining 20% it is accompa-
nied by severe pancreatitis, which may be associated with highmorbidity
and mortality [2].
Although there is a general agreement about delayed cholecystec-
tomy in severe pancreatitis, until the inflammatory process subsided [3],
but in mild to moderate gallstone pancreatitis, in which cholecystectomy
is mandatory to prevent further biliary events, acute cholecystitis,A. Davoodabadi).
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evier Ltd. This is an open accesscholangitis and biliary colic [4], the precise timing of the procedure is
still controversial [5].
In gallstone pancreatitis, surgeons prefer to postpone surgery until
assuring about the safety of an early cholecystectomy, so, they perform it
after relief of abdominal pain, recovery of the inflammatory process and
normalization of liver function tests.
Van Baal MC [6]et al, recommended performing cholecystectomy
during the same hospital admission, Uhl Wet al, recommended it
immediately after recovery of pancreatitis attack [7].
The British Society of Gastroenterology recommends cholecystec-
tomy during the same hospital admission but no more than 2 weeks afterebruary 2020
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ommends performing cholecystectomy during index admission [9].
Shir Li Jee also recommended a median interval time of 6 days from
the diagnosis of ABP as the best time for cholecystectomy [10]. Different
recommendations about the cholecystectomy timing between in-
vestigations and guidelines arise from differing viewpoints and practical
experiments. It may also be due to inadequate prospective randomized
controlled clinical trials, addressing the precise timing and safety of
cholecystectomy. There is also a general consensus about not to delay
cholecystectomy more than 2weeks, because of the possibility of recur-
rent biliary events, which may be life threatening.
Considering 31% recurrences within 2 weeks after discharge, Ito et al,
supposed that a 2 weeks interval may be too long [11]. In a study by
Aboulian et al, [12], intervention during 48 h of admission, without
improvement in abdominal pain or laboratory abnormalities, resulted in
a shorter length of hospital stay and no technical difficulty of the pro-
cedure or peri-operative complication rate. Although this approach
should be further evaluated by high quality studies, it seems that incre-
ment in hospital stay is not necessary.
In addition, standard of care has been improved and now trends are
toward performing earlier cholecystectomy.
With the consideration that even an interval of 3–6 days as early
cholecystectomy, which was recommended in previous studies, is still too
late; this study was conducted to compare the results of very early (within
48 h), versus delayed cholecystectomy (more than 1 week), in mild to
moderate acute biliary pancreatitis.
2. Methods
This randomized clinical trial study was carried out in Shahid
Beheshti Hospital of KAUMS, during September 2016 to Mar 2019. Pa-
tients with the diagnosis of primary episode of mild to moderate ABP
were allocated randomly into early (within 48 h) and delayed groups
(more than 1 week) for cholecystectomy. Demographic data, duration of
procedure, events, relapse, peri-operative complications, conversion rate,
recurrent biliary and total hospital length of stay were recorded and
compared between two groups.
2.1. Definition of moderate gallstone pancreatitis
On the base of Ranson's criteria [13], serum aspartate aminotrans-
ferase (AST) or, serum Lactate (LDH) of more than three times of the
upper limit of normal value, age of less than 70 years, WBC less than 18,
000/μL, and blood glucose less than 220 mg/dL on admission were
considered as the inclusion criteria. On the base of Revised Atlanta
criteria [14]none of the patients had organ failure or systemic compli-
cations, although a few in both groups had transient renal insufficiency
which improved soon after rehydration without any sequel or mortality,
and discharged within the 1st week after operation. Therefore, we
considered them as moderate acute biliary pancreatitis, although, still is
a debate to be considered as category of moderately severe acute
pancreatitis.
2.2. Diagnosis of acute pancreatitis
On base of Revised Atlanta criteria diagnosis of acute pancreatitis was
made in the presence of abdominal pain suggestive of pancreatitis, serum
amylase more than three times of the upper normal value or lipase level
more than three times the upper normal value [14].If the diagnosis was
in doubt, CT-scan was used to confirm acute pancreatitis. Additionally,
the diagnosis of gall stone pancreatitis was also considered if sandy stone
in gallbladder was seen on abdominal ultrasonography. In the absence of
a CBD stone, but suspected cholestasis (bilirubin4 mg/dl without
cholangitis and dilatation of the biliary tree, repeated ultrasonography
(US) or magnetic resonance cholangiopancreatography (MRCP), was also
performed. C reactive protein (CRP) level was used in both groups to2monitor disease progress. If CRP level was not decreasing or when it
reached >150 mg/dL, a contrast-enhanced abdominal computerized to-
mography (CT) scan was performed to assess any possible necrotizing
pancreatitis.
The majority of our patients meet the criteria for acute pancreatitis on
the basis of clinical presentation, laboratory results and (US). CT scan
was used only when CRP level was not decreasing or when it reached
>150.Our current approach in ABP was using MRCP and US instead of
Intra-operative cholangiography. Patients who had no CBD stone, only
underwent cholecystectomy but in patients with documented CBD stone,
endoscopic retrograde cholangiopancreatography (ERCP) and endo-
scopic sphincterotomy (ES) were performed immediately after discharge.
Preoperative ERCP was limited to patients with cholestasis (bilir-
ubin4and CBD dilation. Cholecystectomy for mild to moderate gall-
stone pancreatitis in group 1 was performed before normalization of
serum pancreatic enzymes or resolution of abdominal symptom, but in
group2 it was carried out after them.
2.3. Study design and randomization
Patients were randomly allocated into either a very early group
(within 2days) or group1 (G1) and late (more than 1week) or group2
(G2). Informed consent was obtained from all of the participants.
Some of the patients required additional work up such as cardiologic
assessment, pre-cholecystectomy ERCP and discontinuation of clopi-
dogrel, so they operated in the same admission time and considered as
group 2. This group included 27% of patients but the majority of them
had the criteria of group 1, without additional risk factor. In group1, no
additional work up was needed, and so immediately underwent chole-
cystectomy after obtaining informed consent, regardless of the resolution
of abdominal pain or pancreatic enzyme.
We applied The American Society of Anaesthesiologists Physical
Status ASA-PS classification [14, 15] and Charlson Comorbidity Index
(CCI) to assess patients' physical condition and prognostic criteria of
outcome before surgery [16, 17]. We also used Complexity of surgery
classification according to the Austrian Chamber of Physician [18], and
Clavien-Dindo classification of surgical complications to assess post-
operative complications after surgery [19].
2.4. Sample size calculation
For showing a reduction of recurrent biliary events and complication
with power of 90%- and a two-sided test of 5%, 104 patients had to be
included in each group (a total of 208 patients).
2.5. Inclusion criteria
In this study, adult non-pregnant patients (age range, 18–69 years)
with mild to moderate ABP based on Ranson's score 3 and Revised
Atlanta Criteria were included.
Exclusion criteria: Patients diagnosed with severe pancreatitis (Ran-
son's score 3 or persistent organ failure), multiple organ failure [14],
necrotizing pancreatitis, and concomitant acute cholangitis, at the time
of admission, were excluded.
3. Ethical consideration
This study was approved by Kashan University of Medical Sciences
(KAUMS) ethics committee, http://ethics.research.ac.ir/IR.KAUMS
.MEDNT.REC.1397.006, WHO IRCT (Iranian Registry of Clinical trial
number), IRCT20180205038627N2, and was reported in line with the
CONSORT 2010 checklist of information. For all participants in each
group, the possible complications, advantages and disadvantages of early
or delayed intervention were explained and a written informed consent
was obtained.
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After approval of the study and obtaining a written informed consent
from each patient, demographic characteristics, laboratory values and
peri-operative events were recorded.
Statistical analysis: SPSS version 16 was used for data analysis. Re-
sults were presented as mean  SD with 95%confidence interval (CI).
Independent t-tests were used to assess significant differences between
the two groups. Frequencies were presented for categorical variables, and
chi-square and Fisher's exact tests for qualitative data. Statistical signif-
icance was set at a P value of <0.05.
4.1. Operation
All patients received appropriate pri-operative antibiotic prophylaxis.
Cholecystectomy was performed in standard manner. Majority of the
patients were transferred to ward after surgery and discharged during 48
h, however a few needed to stay in a high-dependency unit bed (HDU) for
better medical care and seldom required ICU care in first 24 h.
4.2. Follow-up
After hospital discharge, patients were visited in the outpatient clinic
1, 2 and 4 month after discharge.
5. Results
The age range was 18–69years with a median of 37.00  11.30 in G1
and 35.48  10.83 in G2 (Table 1). There was no significant difference
between the two groups regarding age, gender and duration of proced-
ure. Duration of hospital stay was significantly longer in G2 (10.35 
1.76 vs. 3.66  1.12, P < 0.001), (Table 1).
Majority of our patients (73%) were normal healthy people (ASA I)
and the rest were in ASA II class, such as controlled diabetes mellitus
(DM) or chronic obstructive pulmonary disease (COPD). No patients had
active hepatitis. In the pre-operative cardiology consultation, low to
moderate risk and ejection fractions of 45–50% were reported. No
problem happened for those with clopidogrel discontinuation. In
Assigned Weights for Diseases, most of our patients had CCI 1–2; some
had CCI 3–4 (e.g., controlled DM and COPD). They had no serious dis-
ease, leukemia or malignancy. CCI was calculated according to the
scoring system established by Charlson et al.21.There were no differ-
ences regarding laboratory data at admission time in the 2 groups. Serum
amylase levels in both groups (813.24 109.73 U/L and 825.37 96.56
U/L) were more than 9 times upper limit of normal (40-85U/L)), and
serum lipase (753.14 139.78 U/L vs. 765.31 23.21 U/L, P ¼ 0.5160)
was also more than 4 fold upper limit of normal (0–160U/L). There was
no differences regarding Ranson's score (0.84 0.99vs. 0.86  1.02, P ¼
0.754).
Therefore, patients based on laboratory data and Ranson's score, had
diagnosed with mild to moderate gallstone pancreatitis. Also, regardingTable 1. Demographic data related to timing of cholecystectomy.
variable Very early group (G1)
n ¼ 104
age 37.00  11.30
Sex
Male 43 (41.3%)
Female 61 (58.7%)
Duration of procedure (minutes) 83.7  .7.49
Hospital stay days 3.66  1.12
Recurrent biliary events 0 (0%)
** Chi-square test.
* T test.
3the Revised Atlanta criteria, they were classified into mild to moderate
categories.There was no significant difference between the two groups
regarding the need for ERCP after cholecystectomy (43 vs. 40, P ¼ 0.67)
(Table 2).
In the 208 patients, the surgical site infection (SSI) rate was 3.3% (n¼
7) so considered as Clavien-Dindo classification of 2 for (SSI) and 0.5%as
Clavien-Dindo III for (biliary leak). No Clavien grade IV complication
occurred during the investigation. Concerning the complexity of the
procedures, according to the Austrian Chamber of Physicians (ERCP ¼
grade 4, cholecystectomy grade 6which expect to have mean length of
stay of 9 days) there were no differences regarding peri-operative com-
plications and conversion rate to open surgery (5.7% vs6.7%; p¼ 0.825).
No choledochal injury happened. We had no recurrent biliary events
in G1, but there were 4 cases in the pre-operative interval in G2,
including gallstone-related symptoms (recurrent abdominal pain, raised
serum amylase), 0% vs. 4%, P < 0.0001.
Two patients in each group had relapse of mild ABP during follow up
that was treated medically. There was one case of biliary leak that
stopped after ERCP (Table 3).
We had no postoperative respiratory failure, or local or systemic
complication, however a few patients had transient renal insufficiency
improved immediately after adequate rehydration in both groups.
Majority of stones had passed through CBD during the first episode of
pancreatitis (hospital stay and immediately after discharge) so, ERCPwas
performed in 83patients (40%), G1 ¼ 43cases, (21%) and G2 ¼ 40cases
(19%). None of patients in the early group and 15 patients (14%) in the
delayed group underwent pre-cholecystectomy ERCP and
esphicterotomy.
6. Discussion
Optimal timing of cholecystectomy has not precisely defined, and
there is still negative conception in some gastroenterologists about early
operation [3, 8, 20, 21, 22]. Surgeons have believed that cholecystec-
tomy during index admission exposed them with a difficult dissection
due to inflammatory tissue and edema caused by pancreatitis, and
possible increasing surgical complications and conversion rate. However,
recent studies confirmed that early cholecystectomy does not increase
intraoperative complications [6, 23, 24, 25].
Shir Li Jee [10], in a study on early cholecystectomy within 6 days
showed no increase in overall conversion rate, duration of surgery, and
morbidity rate. In our study, surgical site infection (SSI) was 3.3% with
no difference between the two groups and was lower than others studies
(3.3% vs. 7.29%) [27] and on the basis of the Clavien-Dindo classifica-
tion, it is compatible with Grade IIIa, with a morbidity rate of 13.8%
[19]. Patients with higher Clavien scores have severe complications and
longer length of hospital stay [19]. Seventy-three percent of our patients
were in ASA-I and CCI scores of 1–2 and the rest were in ASA II, with CCI
scores of 3–4. Lower rate of SSI in our patients may be related to lower
ASA scores and CCI score. In a study conducted by Masoorkhan, SSI inLate group (G2) P value*
n¼(104 (
35.48  10.83 0.324
49 (47.1%) 0.402
55 (52.9%)
81.73  10.43 0.110
10.35  1.76 <0. 001
4 (4%) 0.121*
Table 2. Mean  SD of laboratory data at admission time in the two groups.
Variable Very early (G1) Late (G2) P value*
Ranson's score 0.84  0.99 0.86  1.02 0.754
WBC (/μL) 12000  1610 11610  1820 0.101
BUN (mg/dL) 10.23  1.56 9.90  1.47 0.123
Amylase (U/L) serum 813.24  109.73 825.37  96.56 0.399
lipase (U/L)) serum 753.14  139.78 765.3  123.21 0.516
Total bilirubin (mg/dL) 3.16  0.85 3.16  1.02 0.791
Bilirubin (direct) (mg/dL) 2.12  0.88 2.13  1.00 0.942
ALT (U/L) 366.13  104.73 379.44  114.93 0.366
AST (U/L) 372.57  89.30 368.98  99.41 0.727
ALP(U/L) 341.97  156.93 310.43  166.31 0.161
CRP (mg/L) 110.49  22.27 113.28  21. 5 0.355
LDH (U/L) 446.13  127.29 430.80  128.7 0.389
glucose (mg/L) 100.95  19.48 103.48  21.44 0.375
* Independent sample T test.
Table 3. Complications of surgery in the two groups of cholecystectomy.
Variable Very Early Late early P value
surgical site infections 3 (3%) 4 (4%) P ¼ 1*
bile leak 1 (1.1%) 0 (0%) P ¼ 1*
Mortality rate 0 (0%) 0.0%) NS
Conversion 6 (5.7%) 7 (6.7%) P ¼ 1*
ERCP and ES 43 (41%) 40 (19%) 0.67**
* Fisher's Exact test.
** Chi-square test.
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concluded that ABP does not influence the SSI rate.
The results of the present study showed no significant difference in
conversion rate between the two groups, 6 patients (5.7%) vs. 7 (6.7%)
patients. Also, peri-operative complication rates in the two groups were
the same, which showed no significant difference. The causes of con-
version in our study included unclear anatomy, hemorrhage in the sur-
gical field, intra-abdominal adhesion in calot's triangle and perihepatic
area.
The results of our study were consistent with other studies that
compared cholecystectomy within 48 h with those performed after
improvement of abdominal pain and liver enzymes level [27].
Retrospective studies have revealed that the risk of recurrence of
biliary events following an episode of ABP, after discharge from hospital
and before interval cholecystectomy, is considerable and has been re-
ported between 9% and 60% [26, 30].
We have not recurrent biliary events in early group but in the late
group, it was 4%. However, it is more favourable than other studies [10,
11, 29].
Length of hospital stay in the delayed group was longer in our study in
comparison to very early group (G1) or those reported in the literature
[10, 24, 27, 28, 29], and this may increase the cost of treatment without
any advantage.
We have used sonography and MRCP instead of intra-operative
cholangiography (IOC) and during follow up, only 2% of the cases in
each group had retained stones, which clinically presented with post-
cholecystectomy pancreatitis. This relapse may be due to migration of
biliary sludge or incomplete sphincterotomy. All of these patients
responded to medical treatment. This low relapse rate indicates that4ultrasonography plus MRCP may be sufficient for CBD stone detection. It
seems that the sonographyplus MRCP can replace IOC with the same
efficacy, however it needs further investigations.
In Shir Li study, delayed cholecystectomy had longer overall length of
stay because 24% of the cases were re-admitted for recurrent biliary
events. This may not be so, if cholecystectomy had been performed early
[10].
Many of our patients had abdominal pain and vomiting, as well as
elevated serum pancreatic enzymes, however, cholecystectomy was
performed before resolution of these findings. So, increased serum
pancreatic enzymes or abdominal pain and vomiting may not have
adverse effect on final outcome.
Our current policy was to perform ERCP and endoscopic sphincter-
otomy (ES) in CBD stone immediately after discharge, and preoperative
ERCP was limited to patients with a total bilirubin <4 mg/dl without
cholangitis and CBD dilatation, which strongly suspects to compacted
stones or apparent cholestasis. This was done in the same admission
period.
There is still controversy about the role and timing of ERCP in ABP
and is another cause of delaying cholecystectomy. On the base of
guidelines of American Society for Gastrointestinal Endoscopy, there is
no role for early ERCP in management of mild acute pancreatitis, if there
is no obviously evidence of a retained stone3. Chang et al. [30] showed
that in patients with mild to moderate ABP and retained CBD stones,
preoperative or post-operative complication rate of ERCP is the same,
however the hospital length of stay and costs were significantly fewer in
the postoperative ERCP group.
Conclusion: According to the results of the present study, cholecys-
tectomy within 48 h of admission is safe, time saving and more cost
A. Davoodabadi et al. Heliyon 6 (2020) e03388beneficial. There is no difficulty in the technical aspect of the procedure,
as well. Conversion rate, duration of surgery, and peri-operative com-
plications are the same. We recommend very early cholecystectomy as
standard of care in mild to moderate ABP, although it may need more
supporting data and studies.
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